|
Name |
Isosulochrin
|
Molecular Formula | C17H16O7 | |
IUPAC Name* |
methyl 2-(2,6-dihydroxy-4-methylbenzoyl)-3-hydroxy-5-methoxybenzoate
|
|
SMILES |
CC1=CC(=C(C(=C1)O)C(=O)C2=C(C=C(C=C2O)OC)C(=O)OC)O
|
|
InChI |
InChI=1S/C17H16O7/c1-8-4-11(18)15(12(19)5-8)16(21)14-10(17(22)24-3)6-9(23-2)7-13(14)20/h4-7,18-20H,1-3H3
|
|
InChIKey |
XKIBNYJGNBTYMP-UHFFFAOYSA-N
|
|
Synonyms |
Isosulochrin; O8CBB83PPJ; 77282-68-9; methyl 2-(2,6-dihydroxy-4-methylbenzoyl)-3-hydroxy-5-methoxybenzoate; Methyl 2-(2,6-dihydroxy-4-methylbenzoyl)-3-hydroxy-5-methoxybe..; Benzoic acid, 2-(2,6-dihydroxy-4-methylbenzoyl)-3-hydroxy-5-methoxy-, methyl ester; UNII-O8CBB83PPJ; MLS000877019; MEGxm0_000016; CHEMBL1387766; ACon0_000933; ACon1_000868; DTXSID501346187; HMS2269B13; ZINC13660257; NCGC00169280-01; SMR000440672; BRD-K50598371-001-01-6; Q27285475; Methy 2-(2,6-dihydroxy-4-methylbenzoyl)-3-hydroxy-5-methoxybenzoate; NCGC00169280-03!methyl 2-(2,6-dihydroxy-4-methylbenzoyl)-3-hydroxy-5-methoxybenzoate
|
|
CAS | 77282-68-9 | |
PubChem CID | 16681742 | |
ChEMBL ID | CHEMBL1387766 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 332.3 | ALogp: | 2.9 |
HBD: | 3 | HBA: | 7 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 113.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 24 | QED Weighted: | 0.583 |
Caco-2 Permeability: | -5.086 | MDCK Permeability: | 0.00001240 |
Pgp-inhibitor: | 0.013 | Pgp-substrate: | 0.004 |
Human Intestinal Absorption (HIA): | 0.098 | 20% Bioavailability (F20%): | 0.034 |
30% Bioavailability (F30%): | 0.82 |
Blood-Brain-Barrier Penetration (BBB): | 0.033 | Plasma Protein Binding (PPB): | 98.77% |
Volume Distribution (VD): | 0.394 | Fu: | 2.72% |
CYP1A2-inhibitor: | 0.949 | CYP1A2-substrate: | 0.916 |
CYP2C19-inhibitor: | 0.435 | CYP2C19-substrate: | 0.062 |
CYP2C9-inhibitor: | 0.696 | CYP2C9-substrate: | 0.825 |
CYP2D6-inhibitor: | 0.529 | CYP2D6-substrate: | 0.351 |
CYP3A4-inhibitor: | 0.664 | CYP3A4-substrate: | 0.141 |
Clearance (CL): | 11.79 | Half-life (T1/2): | 0.582 |
hERG Blockers: | 0.037 | Human Hepatotoxicity (H-HT): | 0.049 |
Drug-inuced Liver Injury (DILI): | 0.95 | AMES Toxicity: | 0.732 |
Rat Oral Acute Toxicity: | 0.032 | Maximum Recommended Daily Dose: | 0.856 |
Skin Sensitization: | 0.288 | Carcinogencity: | 0.028 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.943 |
Respiratory Toxicity: | 0.147 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005979 | 0.795 | D07MGA | 0.289 | ||||
ENC000936 | 0.778 | D06GCK | 0.279 | ||||
ENC004806 | 0.770 | D04AIT | 0.271 | ||||
ENC002109 | 0.711 | D0Y7PG | 0.269 | ||||
ENC002663 | 0.634 | D00KRE | 0.265 | ||||
ENC005169 | 0.628 | D0B0AX | 0.263 | ||||
ENC002461 | 0.618 | D04OSE | 0.260 | ||||
ENC002468 | 0.617 | D0R1RS | 0.255 | ||||
ENC005978 | 0.617 | D0K8KX | 0.253 | ||||
ENC005170 | 0.612 | D0A1DH | 0.252 |